HomeEYPT • NASDAQ
Follow
Eyepoint Pharmaceuticals Inc
Previous close
$20.94
Day range
$17.02 - $20.80
Year range
$4.73 - $30.99
Market cap
872.04M USD
Avg Volume
766.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 14.03M | 33.18% |
Operating expense | 9.66M | -30.90% |
Net income | -14.10M | 67.55% |
Net profit margin | -100.51 | 75.64% |
Earnings per share | -0.33 | 45.83% |
EBITDA | -15.04M | 33.74% |
Effective tax rate | -0.59% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 331.05M | 129.00% |
Total assets | 355.18M | 96.93% |
Total liabilities | 88.86M | 5.80% |
Total equity | 266.32M | — |
Shares outstanding | 49.83M | — |
Price to book | 3.86 | — |
Return on assets | -14.71% | — |
Return on capital | -22.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -14.10M | 67.55% |
Cash from operations | -23.11M | -83.58% |
Cash from investing | -47.15M | -243.23% |
Cash from financing | 218.48M | 376,798.28% |
Net change in cash | 148.23M | 631.23% |
Free cash flow | -6.39M | -29.19% |
About
EyePoint Pharmaceuticals, Inc. pSivida is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Wikipedia
Founded
1987
Headquarters
Website
Employees
121
